Morphosys Ag Ord

38.220-5.3800-12.34%Vol 1.00K1Y Perf -64.53%
Nov 22nd, 2021 12:22
BID0.0000 ASK0.0000
Open38.820 Previous Close43.600
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.39
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     45.51
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha-0.01 Standard Deviation0.11
Beta0.76 

Today's Price Range

38.22038.820

52W Range

38.220114.35

5 Year PE Ratio Range

-42.800102.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.00%
1 Month
-16.52%
3 Months
-25.93%
6 Months
-54.90%
1 Year
-64.53%
3 Years
-65.97%
5 Years
-18.18%
10 Years
0.00%

TickerPriceChg.Chg.%
MPSYF38.220-5.3800-12.34
AAPL175.083.90002.28
GOOG2 974.4113.68000.46
MSFT334.970.05000.01
XOM62.450.18000.29
WFC49.41-0.8400-1.67
JNJ164.340.98000.60
FB330.567.75002.40
GE98.280.73000.75
JPM160.71-1.8600-1.14
Financial StrengthValueIndustryS&P 500US Markets
4.80
5.00
0.35
0.54
-1.40
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
80.30
-77.30
-71.10
-88.80
-91.58
RevenueValueIndustryS&P 500US Markets
183.60M
5.38
46.15
31.50
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.00K
Shares Outstanding0
Shares Float34.14M
Trades Count6
Dollar Volume533
Avg. Volume1.51K
Avg. Weekly Volume560
Avg. Monthly Volume1.38K
Avg. Quarterly Volume367
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Morphosys Ag Ord

MorphoSys AG is a biotechnology company that develops therapeutic antibodies. The company reports two business segments: partnered discovery and proprietary development. Its partnered discovery segment applies the research, development, and optimization of antibody drug candidates in partnerships with pharmaceutical and biotechnology companies. MorphoSys' profits in this segment stem from successful programs via milestone payments and potential royalties on product sales. In its proprietary development segment, the company develops antibodies that concentrate on inflammatory and autoimmune diseases, as well as cancer and infectious diseases.

CEO:

Telephone: +49 89899270

Address: Semmelweisstrasse 7, Planegg 82152, , DEU

Number of employees: 405

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

64%36%

News